| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.36▲ | 0.36▲ | 0.36▲ | 0.37▼ | 0.38▼ |
| MA10 | 0.36▲ | 0.37▼ | 0.37▼ | 0.37▼ | 0.38▼ |
| MA20 | 0.37▼ | 0.37▼ | 0.37▼ | 0.38▼ | 0.41▼ |
| MA50 | 0.38▼ | 0.39▼ | 0.39▼ | 0.38▼ | 0.97▼ |
| MA100 | 0.38▼ | 0.38▼ | 0.38▼ | 0.46▼ | 1.73▼ |
| MA200 | 0.37▼ | 0.38▼ | 0.39▼ | 0.87▼ | 7.02▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.000▼ | -0.001▼ | -0.002▼ | 0.036▲ |
| RSI | 45.181▼ | 41.390▼ | 41.251▼ | 41.863▼ | 36.879▼ |
| STOCH | 46.255 | 24.682 | 14.095▼ | 30.102 | 45.606 |
| WILL %R | -59.559 | -77.178▼ | -78.682▼ | -87.977▼ | -84.483▼ |
| CCI | -6.308 | -65.983 | -73.951 | -144.923▼ | -70.304 |
|
Wednesday, August 12, 2026 08:25 AM
In June 2026, Soligenix, Inc. (NASDAQ: SNGX) announced that it would be applying for funding from a recent call for proposals from the Coalition for Epidemic Preparedness Innovations (CEPI) regarding ...
|
|
Soligenix (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results
Wednesday, April 01, 2026 10:04 AM
Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including advancing its Phase 3 FLASH2 trial of HyBryte(TM) for cutaneous T-cell lymphoma with ...
|
|
Tuesday, March 24, 2026 09:34 AM
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/09/26 | 0.3597 | 0.3686 | 0.3597 | 0.3652 | 146,814 |
| 10/09/26 | 0.36 | 0.3746 | 0.36 | 0.3601 | 84,933 |
| 09/09/26 | 0.3774 | 0.3899 | 0.366 | 0.367 | 126,360 |
| 08/09/26 | 0.3833 | 0.3893 | 0.375 | 0.3779 | 95,221 |
| 04/09/26 | 0.3832 | 0.3848 | 0.38 | 0.38 | 108,025 |
| 03/09/26 | 0.3899 | 0.3899 | 0.382 | 0.3832 | 59,893 |
| 02/09/26 | 0.375 | 0.3895 | 0.3721 | 0.3817 | 89,957 |
| 01/09/26 | 0.374 | 0.3895 | 0.3712 | 0.376 | 120,227 |
| 31/08/26 | 0.375 | 0.3912 | 0.3589 | 0.38 | 400,287 |
| 28/08/26 | 0.3778 | 0.39 | 0.3748 | 0.3768 | 139,017 |
|
|
||||
|
|
||||
|
|